Boston Scientific Closes EndoChoice Acquisition Acquisition Expands Endoscopy Portfolio PR Newswire MARLBOROUGH, Mass., Nov. 22, 2016 MARLBOROUGH, Mass., Nov. 22, 2016 /PRNewswire/ -- Boston...
Boston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice PR Newswire MARLBOROUGH, Mass., Nov. 4, 2016 MARLBOROUGH, Mass., Nov. 4, 2016 /PRNewswire/ -- Boston...
Boston Scientific Announces Results For Third Quarter 2016 PR Newswire MARLBOROUGH, Mass., Oct. 26, 2016 MARLBOROUGH, Mass., Oct. 26, 2016 /PRNewswire/ -- Boston Scientific Corporation (NYSE:...
ENDOCHOICE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of EndoChoice Holdings, Inc. (GI) Over the Proposed Sale of the Company to Boston Scientific Corporation Faruqi...
Boston Scientific Commences Cash Tender Offer For All Shares Of EndoChoice For $8.00 Per Share In Cash PR Newswire MARLBOROUGH, Mass., Oct. 7, 2016 MARLBOROUGH, Mass., Oct. 7, 2016 /PRNewswire/...
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...
Harwood Feffer LLP Announces Investigation of EndoChoice Holdings, Inc. PR Newswire NEW YORK, Sept. 27, 2016 NEW YORK, Sept. 27, 2016 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is...
Rigrodsky & Long, P.A.: Do you own shares of EndoChoice Holdings, Inc. (NYSE: GI)? Did you purchase any of your shares prior to September 27, 2016? Do you think the proposed...
Boston Scientific to Acquire EndoChoice Acquisition Will Expand Endoscopy Gastroenterology Portfolio PR Newswire MARLBOROUGH, Mass. and ALPHARETTA, Ga., Sept. 27, 2016 MARLBOROUGH, Mass. and...
Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against EndoChoice Holdings, Inc. (NYSE: GI) in the Superior Court of the State of Georgia...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales